Cell-specific Delivery of a Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor to Proximal Tubular Cells for the Treatment of Renal Fibrosis-Reference-Cited by-同舟云学术

Cell-specific Delivery of a Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor to Proximal Tubular Cells for the Treatment of Renal Fibrosis

Published:2008-01-09 Issue:10 Volume:25 Page:2427-2439
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Prakash Jai,de Borst Martin H.,van Loenen-Weemaes Annemiek M.,Lacombe Marie,Opdam Frank,van Goor Harry,Meijer Dirk K. F.,Moolenaar Frits,Poelstra Klaas,Kok Robbert J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s11095-007-9515-x

Reference26 articles.

1. E. P. Bottinger, and M. Bitzer. TGF-beta signaling in renal disease. J. Am. Soc. Nephrol 13:2600–2610 (2002).

2. M. Zeisberg, and R. Kalluri. The role of epithelial-to-mesenchymal transition in renal fibrosis. J. Mol. Med 82:175–181 (2004).

3. A. A. Eddy. Molecular insights into renal interstitial fibrosis. J. Am. Soc. Nephrol 7:2495–2508 (1996).

4. H. W. Schnaper, T. Hayashida, and A. C. Poncelet. It’s a Smad world: regulation of TGF-beta signaling in the kidney. J. Am. Soc. Nephrol 13:1126–1128 (2002).

5. N. J. Laping. ALK5 inhibition in renal disease. Curr. Opin. Pharmacol 3:204–208 (2003).

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A quantitative review of nanotechnology‐based therapeutics for kidney diseases;WIREs Nanomedicine and Nanobiotechnology;2024-03

2. Advances in drug delivery-based therapeutic strategies for renal fibrosis treatment;Journal of Materials Chemistry B;2024

3. Omeprazole induces profibrotic gene expression in rat kidney: implication of TGF-β/Smad signaling pathway;Drug and Chemical Toxicology;2023-11-20

4. Biopolymer-Based Nanosystems: Potential Novel Carriers for Kidney Drug Delivery;Pharmaceutics;2023-08-17

5. Is the proximal tubule the focus of tubulointerstitial fibrosis?;Heliyon;2023-02